Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio (2014 - 2024)
Scinai Immunotherapeutics (SCNI) reported Interest Coverage Ratio of 1.65 for Q4 2024, up 90.24% on a YoY basis from 0.87 in Q1 2024, and down 112.22% sequentially from 13.48 in Q1 2024.
Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio (2014 - 2024) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 11 years of Interest Coverage Ratio data on file, last reported at 1.65 in Q4 2024.
- For the quarter ending Q4 2024, Interest Coverage Ratio rose 90.24% year-over-year to 1.65; the trailing twelve-month figure through Mar 2026 stood at 6.19 (up 30.01% YoY), and the FY2025 full-year result was 0.34, up 6.24% from the prior year.
- Interest Coverage Ratio retreated to 1.65 in Q4 2024, from 13.48 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 135.47 in Q1 2020 to a low of 193.07 in Q3 2020.
- A 5-year average of 0.3 and a median of 2.88 in 2021 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 3724.82% in 2020, while the deepest fall reached 713.18% in 2020.
- Tracing SCNI's Interest Coverage Ratio over 5 years: stood at 20.81 in 2020, then gained by 27.71% to 26.58 in 2021, then tumbled by 120.83% to 5.54 in 2022, then plunged by 204.89% to 16.88 in 2023, then jumped by 90.24% to 1.65 in 2024.
- Business Quant data shows SCNI's Interest Coverage Ratio at 1.65 in Q4 2024, 13.48 in Q1 2024, and 16.88 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.65 |
| Mar 31, 2024 | 13.48 |
| Dec 31, 2023 | -16.88 |
| Mar 31, 2023 | 4.39 |
| Dec 31, 2022 | -5.54 |
| Sep 30, 2022 | 0.85 |
| Jun 30, 2022 | -0.90 |
| Mar 31, 2022 | 3.55 |
| Dec 31, 2021 | 26.58 |
| Sep 30, 2021 | 2.94 |
| Jun 30, 2021 | 2.88 |
| Mar 31, 2021 | 2.58 |
| Dec 31, 2020 | 20.81 |
| Sep 30, 2020 | -193.07 |
| Mar 31, 2020 | 135.47 |
| Sep 30, 2019 | 31.49 |
| Jun 30, 2019 | 0.10 |
| Mar 31, 2019 | 3.54 |
| Dec 31, 2018 | -85.28 |
| Sep 30, 2018 | 3.65 |